Ad is loading...
RNA
Price
$42.18
Change
-$7.79 (-15.59%)
Updated
Nov 15 closing price
107 days until earnings call
SWTX
Price
$36.45
Change
-$0.10 (-0.27%)
Updated
Nov 15 closing price
107 days until earnings call
Ad is loading...

RNA vs SWTX

Header iconRNA vs SWTX Comparison
Open Charts RNA vs SWTXBanner chart's image
Avidity Biosciences
Price$42.18
Change-$7.79 (-15.59%)
Volume$2M
CapitalizationN/A
SpringWorks Therapeutics
Price$36.45
Change-$0.10 (-0.27%)
Volume$3.82M
CapitalizationN/A
RNA vs SWTX Comparison Chart
Loading...
RNA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
SWTX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
RNA vs. SWTX commentary
Nov 17, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RNA is a Sell and SWTX is a Hold.

COMPARISON
Comparison
Nov 17, 2024
Stock price -- (RNA: $42.18 vs. SWTX: $36.45)
Brand notoriety: RNA and SWTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: RNA: 149% vs. SWTX: 337%
Market capitalization -- RNA: $5.03B vs. SWTX: $2.71B
RNA [@Biotechnology] is valued at $5.03B. SWTX’s [@Biotechnology] market capitalization is $2.71B. The market cap for tickers in the [@Biotechnology] industry ranges from $472.8B to $0. The average market capitalization across the [@Biotechnology] industry is $2.66B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RNA’s FA Score shows that 0 FA rating(s) are green whileSWTX’s FA Score has 0 green FA rating(s).

  • RNA’s FA Score: 0 green, 5 red.
  • SWTX’s FA Score: 0 green, 5 red.
According to our system of comparison, SWTX is a better buy in the long-term than RNA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RNA’s TA Score shows that 5 TA indicator(s) are bullish while SWTX’s TA Score has 5 bullish TA indicator(s).

  • RNA’s TA Score: 5 bullish, 5 bearish.
  • SWTX’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, both RNA and SWTX are a good buy in the short-term.

Price Growth

RNA (@Biotechnology) experienced а -9.72% price change this week, while SWTX (@Biotechnology) price change was +7.24% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.58%. For the same industry, the average monthly price growth was -5.90%, and the average quarterly price growth was -0.16%.

Reported Earning Dates

RNA is expected to report earnings on Mar 04, 2025.

SWTX is expected to report earnings on Mar 04, 2025.

Industries' Descriptions

@Biotechnology (-8.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RNA($5.03B) has a higher market cap than SWTX($2.71B). RNA YTD gains are higher at: 366.077 vs. SWTX (-0.137). RNA has higher annual earnings (EBITDA): -282.67M vs. SWTX (-318.71M). RNA has more cash in the bank: 1.3B vs. SWTX (384M). SWTX has less debt than RNA: SWTX (7.06M) vs RNA (8.38M). SWTX has higher revenues than RNA: SWTX (86.2M) vs RNA (10.6M).
RNASWTXRNA / SWTX
Capitalization5.03B2.71B186%
EBITDA-282.67M-318.71M89%
Gain YTD366.077-0.137-267,241%
P/E RatioN/AN/A-
Revenue10.6M86.2M12%
Total Cash1.3B384M338%
Total Debt8.38M7.06M119%
TECHNICAL ANALYSIS
Technical Analysis
RNASWTX
RSI
ODDS (%)
Bearish Trend 3 days ago
87%
Bearish Trend 3 days ago
78%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
82%
Bearish Trend 3 days ago
90%
Momentum
ODDS (%)
Bullish Trend 3 days ago
86%
Bullish Trend 3 days ago
85%
MACD
ODDS (%)
Bullish Trend 3 days ago
85%
Bullish Trend 3 days ago
85%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
83%
Bullish Trend 3 days ago
84%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
85%
Bullish Trend 3 days ago
84%
Advances
ODDS (%)
Bullish Trend 11 days ago
86%
Bullish Trend 4 days ago
82%
Declines
ODDS (%)
Bearish Trend 3 days ago
84%
Bearish Trend 6 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
87%
Bearish Trend 3 days ago
88%
Aroon
ODDS (%)
Bullish Trend 3 days ago
81%
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Ad is loading...
RNA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
SWTX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SSFI21.23N/A
N/A
Day Hgn/Nd Dvs Rsch Smt Sct Fxd Inc ETF
FTSL46.36-0.01
-0.02%
First Trust Senior Loan ETF
BFEB42.60-0.12
-0.27%
Innovator U.S. Equity Buffer ETF™ - Feb
DRIV23.08-0.08
-0.35%
Global X Atnms & Elctrc Vhcls ETF
UCYB45.70-1.96
-4.11%
ProShares Ultra Nasdaq Cybersecurity

RNA and

Correlation & Price change

A.I.dvisor indicates that over the last year, RNA has been loosely correlated with DYN. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if RNA jumps, then DYN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RNA
1D Price
Change %
RNA100%
-15.59%
DYN - RNA
49%
Loosely correlated
-6.33%
RXRX - RNA
41%
Loosely correlated
-10.64%
SWTX - RNA
40%
Loosely correlated
-0.27%
ALEC - RNA
40%
Loosely correlated
-17.21%
VCYT - RNA
40%
Loosely correlated
-2.97%
More

SWTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, SWTX has been loosely correlated with AMLX. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if SWTX jumps, then AMLX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SWTX
1D Price
Change %
SWTX100%
-0.27%
AMLX - SWTX
40%
Loosely correlated
-5.18%
RNA - SWTX
39%
Loosely correlated
-15.59%
BCRX - SWTX
39%
Loosely correlated
-5.64%
RVMD - SWTX
39%
Loosely correlated
-3.90%
CHRS - SWTX
37%
Loosely correlated
-3.70%
More